Companies Directory

EpiValence is a highly focussed manufacturer of select niche chemicals, dedicated to providing the highest quality products and services on a Global basis to meet customer requirements now and in the future. Our continuing success is founded on three principles: uncompromising commitment to the highest standards of product quality, purity, and consistency; the establishment and maintenance of genuinely interactive relationships with customers; and a leading-edge, proactive approach to the rapidly evolving electronics market globally. PRODUCTS & SERVICES: ◾ Speciality chemicals for electronics (ALD, CVD, MOCVD, PRECURSORS) ◾ Solution-based products for printed electronics ◾ High performance vessels ◾ Bubbler reuse services ◾ Speciality gases EpiValence continues to be recognized by our customers as the leading supplier of niche chemicals. This means executing all processes flawlessly, effectively and efficiently while bringing more value to our customers. EpiValence strives to bring more resources closer to our customers to help make companies such as yours more successful. The continuing success of EpiValence is founded on three principles: uncompromising commitment to the highest standards of product quality, purity, and consistency; the establishment and maintenance of genuinely interactive relationships with customers; and a leading-edge, proactive approach to the rapidly evolving electronics market worldwide.

Epividian advances the mission of medicine by empowering and providing novel research services for clinical practice, clinical research, academic, public health and regulatory purposes. Our unique approach combines real world clinical data throughout the medical ecosystem from clinical research to clinical application. Point-of-care observational data from the doctor-patient encounter is used to support real-world medical research. Our mission is the mission of medicine: solving complex problems to improve the health of individuals and the public. The OPERA® database and research network (Observational Pharmaco-Epidemiology Research & Analysis) is a multi-site observational database built from the complete patient health records managed in Electronic Health Record (EHR) systems from more than 400 participating caregivers across 54 cities throughout the U.S. These physicians and other healthcare workers have documented the care of nearly 930,000 patients in these EHRs, including 93,000 patients who are HIV positive, representing about 8% of all the HIV+ patients linked to care in the U.S. The OPERA® database is refreshed from these EHR databases at each clinic on a daily basis, making the OPERA® database the largest continuously operating cohort of HIV+ patients in the U.S. Epividian provides these clinicians with a variety of meaningful analytical reports and research services supporting the day-to-day care of patients and the management of their patient population. Because these clinicians are not only sharing data but also are regular consumers of the CHORUS™ practice reports, all parties have a vested interest in maintaining the completeness and accuracy of the medical records stored in the EHR systems. Additionally, some of the clinicians in the network also utilize the OPERA® database for identifying candidates for clinical trials they are conducting and/or using the database for various non-interventional studies and papers. Epividian is dedicated to improving health outcomes. Using longitudinal observational data gathered from clinical encounters, Epividian enables and facilitates sophisticated interventional and non-interventional research. Through our longitudinal observational database research engine and our CHORUS service, Epividian is committed to: - Enhancing the doctor-patient relationship by helping doctors spend more time with patients and less time on report generation - Protecting and alerting patients from and about possible side effects through constant data monitoring - Bridging the gap between clinical medicine and clinical research - Improving public health and understanding the impact of interventions

Epix Healthcare is a leader in providing comprehensive outsourced clinical services for community hospitals, office-based facilities and surgery centers nationwide. We have provided patients with exceptional care and strived to surpass our clients´ expectations for 20 years. At Epix, we believe building a strong, local team and culture is the essential ingredient today for a successful practice. As a true partner with your facility’s clinical leadership team, we feel it’s necessary for the anesthesia provider and hospitalist to reach beyond their base clinical and administrative duties to proactively partner with hospital leadership to better coordinate and integrate care. Our innovative approach to clinical outsourcing is designed to drive growth and not only meet, but also exceed your facility’s needs.

Το EPIXEIREIN.GR απευθύνεται σε όλες τις Μικρές επιχειρήσεις, τους Ελεύθερους Επαγγελματίες, και τους Νέους ανθρώπους που αναζητούν βοήθεια στο Μάρκετινγκ και την Ανάπτυξη της δουλειάς τους. Ιδρυτής και ιδιοκτήτης του Epixeirein.gr είναι ο Βασίλης Δ. Παππάς, Σύμβουλος Επιχειρήσεων & Μάρκετινγκ (BA, MBA in Marketing), με πολυετή εμπειρία στην Συμβουλευτική Μάρκετινγκ και τα Προγράμματα επιδοτήσεων. Ειδικευόμαστε στον Στρατηγικό σχεδιασμό μικρών επιχειρήσεων, την δημιουργία πλάνου Μάρκετινγκ μιας μικρής επιχείρησης, την υποστήριξη και καθοδήγιση στην ίδρυση και ανάπτυξη μιας νέας επιχείρησης, καθώς και στην υποβολή και ολοκλήρωση επιδοτούμενων Προγραμμάτων από την Ευρωπαϊκή Ένωση. Στο Epixeirein.gr παρέχουμε Προσωπική Συμβουλευτική και καθοδίγηση (Marketing Coaching) σε ζητήματα Marketing και Ανάπτυξης μικρών επιχειρήσεων, ενω συχνά διοργανώνουμε σεμινάρια και Webinars. Για να δείτε τον τρόπο που δουλεύουμε και σκεφτόμαστε - ΜΠΟΡΕΙΤΕ να κατεβάστε εντελώς ΔΩΡΕΑΝ ένα eBook 21 σελίδων όπου θα βρείτε τι σημαίνει Μάρκετινγκ και Πως θα ξεκινήσετε να το εφαρμόζετε στην επιχείρηση σας. Κατεβάστε το εδώ http://epixeirein.gr/dorean-marketing-ebook/

EPIXPERT offers comprehensive solutions for managing epidemic risk through consulting, infrastructure audits and upgrades, algorithmic risk scoring, antibody screening and PCR testing, and employee training.

On August 12, 2022, Epizyme was acquired by Ipsen, expanding Ipsen’s oncology portfolio. Epizyme now operates as an Ipsen company with a shared goal of delivering innovative treatment options to underserved patients. Ipsen is a global specialty-driven biopharmaceutical group focused on innovation and Specialty Care. It develops and commercializes innovative medicines in three key therapeutic areas - Oncology, Neuroscience and Rare Disease. Its commitment to oncology is exemplified through its growing portfolio of key therapies for prostate cancer, neuroendocrine tumors, renal cell carcinoma and pancreatic cancer. Neuroscience is advancing at an unprecedented rate and Ipsen is at the forefront of this transformation.

On August 12, 2022, Epizyme was acquired by Ipsen, expanding Ipsen’s oncology portfolio. Epizyme now operates as an Ipsen company with a shared goal of delivering innovative treatment options to underserved patients. Ipsen is a global specialty-driven biopharmaceutical group focused on innovation and Specialty Care. It develops and commercializes innovative medicines in three key therapeutic areas - Oncology, Neuroscience and Rare Disease. Its commitment to oncology is exemplified through its growing portfolio of key therapies for prostate cancer, neuroendocrine tumors, renal cell carcinoma and pancreatic cancer. Neuroscience is advancing at an unprecedented rate and Ipsen is at the forefront of this transformation.

On August 12, 2022, Epizyme was acquired by Ipsen, expanding Ipsen’s oncology portfolio. Epizyme now operates as an Ipsen company with a shared goal of delivering innovative treatment options to underserved patients. Ipsen is a global specialty-driven biopharmaceutical group focused on innovation and Specialty Care. It develops and commercializes innovative medicines in three key therapeutic areas - Oncology, Neuroscience and Rare Disease. Its commitment to oncology is exemplified through its growing portfolio of key therapies for prostate cancer, neuroendocrine tumors, renal cell carcinoma and pancreatic cancer. Neuroscience is advancing at an unprecedented rate and Ipsen is at the forefront of this transformation.

EPK Group is the leading bearing manufacturer from Russian Federation. Main specializes: Manufacturing and distribution of bearings, parts and assemblies; pre-delivery and post-delivery service; research and development activities. Nowadays, EPK Group brings together 5 bearing plants: EPK-Novie Tekhnologii, EPK Volzhsky, EPK Samara, EPK Saratov and EPK Stepnogorsk; 2 Research and Developing centers with laboratories and facilities; Trade House EPK (TD EPK) – a division which is responsible for sales, marketing and aftersales technical support. Moreover, a joint venture (with American company Amsted Rail) "EPK-Brenco"​. Power of the aforementioned plants allow to develop practically any constructive groups of bearings in a short time period, possess huge experiences in production and designing of bearings. EPK Group produce bearings for Railroad Engineering; Aerospace Industry; Automotive, Agricultural Engineering Industry and Industrial Sector. EPK advantages: quality, wide product range, flexibility of customer service. Distribution of all the EPK plants products is performed by a united service-sales organization EPK Trade House Ltd., which has representative offices all over Russia and abroad. Supply of products to large companies is performed by the EPK Trade House directly, which contributes to maintenance of contacts with the customers and quick and efficient responses to demands and expectations of every client. Services rendered by EPK Trading House ensure significant enlargement of life cycle for bearings used in heavy demanding assemblies. The Technical Service Group experts perform bearing condition diagnosis, mounting and dismounting, training of the customer technical personnel.

Plastic Injection Molding Company Strategically located in Monterrey Mexico, EPKAMEX can service clients on the Maquiladora Strip , Monterrey-Saltillo area, and up to the United States. Servicing the automotive,home appliance and POP markets since 2001 IATF/TS 16949 Certificate ISO 9000:2015 Certificate UL Approved Molder 30 Machines from 30-8500 Tons Inhouse Toolshop Metrology Lab